MAB Chair and Cambium’s Medical Monitor, Woolfson Eye Institute, Atlanta, Georgia

Doyle Stulting, M.D., Ph.D. is Director of the Stulting Research Center, Woolfson Eye Institute, Atlanta, GA, Professor of Ophthalmology Emeritus, Emory University, and Adjunct Professor of Ophthalmology, the Moran Eye Institute, Salt Lake City, UT.

He has performed refractive surgery for more than 20 years, participating in the physician-sponsored clinical investigation of LASIK before the first refractive laser was approved by the FDA in the United States. He also performs routine and complex cataract surgery, as well as corneal transplantation. Dr. Stulting specializes in the management of keratoconus and corneal ectasia following LASIK, including corneal collagen cross-linking performing multiple clinical trials for the procedure since 2008.

Baylor College of Medicine, Houston, Texas

Stephen C. Pflugfelder, MD, is professor and holder of the James and Margaret Elkins Chair and director of the Ocular Surface Center in the department of ophthalmology at Baylor College of Medicine. He specializes in cornea, ocular surface and tear disorders. Dr. Pflugfelder’s research interests include pathogenesis of desiccation-induced inflammation and autoimmunity on the ocular surface. He has published more than 350 peer-reviewed articles and numerous book chapters. He is past president of the International Ocular Surface Society and has served on the editorial boards of Investigative Ophthalmology and Visual Science (associate editor), American Journal of Ophthalmology (associate editor), Scientific Reports, Cornea and The Ocular Surface. He serves as the Cornea Trustee on the ARVO Board. Dr. Pflugfelder received his medical degree at the State University of New York Upstate College of Medicine and completed his ophthalmology residency at the Baylor College of Medicine and cornea fellowship at the Bascom Palmer Eye Institute, University of Miami.

Professor of Ophthalmology, Duke University

Dr. Perez joined Duke Ophthalmology in September 2017 as Professor of Ophthalmology.  He is an established clinician-scientist investigator in the field of ocular immunology and ocular surface diseases and is Director of Duke Eye Center’s newly launched Ocular Immunology Center. Dr. Perez spends sixty percent of his time in his laboratory researching ocular immunology and transplantation. He complements this with his work as Director of the Ocular Surface Program, evaluating and treating patients with ocular inflammatory diseases and conditions of the anterior segment. In addition to ocular surface, he will also manage patients with uveitis, transplantation and diseases of the eye that also have inflammation.

Cleveland Clinic, Cleveland, Ohio

Professor of Ophthalmology Director of Corneal Research Cornea and Refractive Surgery Fellowship Director Staff Refractive and Corneal Surgeon Cole Eye Institute The Cleveland Clinic Trusted LASIK Surgeons™

Dr. Steven Wilson treats patients seeking LASIK, refractive surgery and corneal diseases from Cleveland, Akron, Canton, and Youngstown and from throughout Ohio, as well from Erie, Pennsylvania

Director of Corneal Services, Kentucky Eye Institute, Lexington KY

Paul M. Karpecki, OD, FAAO, received his doctor of optometry degree from Indiana University and completed a fellowship in medical cornea and refractive surgery in Kansas City in affiliation with the Pennsylvania College of Optometry, now Salus University. He currently serves as Clinical Director, Advanced Ocular Surface Disease at Kentucky Eye Institute in Lexington KY.

Dr. Karpecki was appointed to the Delphi International Society at Wilmer-Johns Hopkins, which included the top 25 dry eye experts in the world and the National Eye Institute’s Dry Eye Committee to provide insights around dry eye and women. He also co-chaired the Dry Eye Summit for the profession, was a director in the CJO Optometric Dry Eye Guidelines for EyeCare, was recently selected for the DEWS II Diagnostic subcommittee and most recently appointed co-chair of the Tear Film and Ocular Surface Society Symposium in 2016 taking place in Montpellier, France. He has over two decades experience in running some of the largest dedicated dry eye clinics in the United States.

Duke Medical School, Duke University, Durham, North Carolina

Dr. Chao’s research interests are in two broad areas, clinical hematopoietic stem cell and cord blood transplantation and in the laboratory studies related to graft vs. host disease and immune reconstitution. On the clinical side they are currently conducting approximately 50 different clinical protocols ranging from preparatory regimens, supportive care studies and disease specific protocols. Most of these clinical studies are centered around studies of the sources of stem cells and the methods to improve the long term outcome. There are exploratory protocols for novel therapies such as dendritic cell therapy for several malignancies, antiangiogenesis therapy, graft engineering to prevent graft-versus-host disease and antigen specific T cells or non specific NK cells to prevent relapse. Moreover a strong focus of the program is to develop cord-blood transplantation for adult patients with hematologic malignancies. The laboratory studies center on understanding the immunological events that occur with graft-vs-host disease and methods to prevent this disease. The current efforts focus on understanding murine reconstitution following transplantation, use of a peptide polymer to block MHC class II recognition of minor histocompatibility antigens, use of T cell engineering to prevent graft-versus-host disease at the same time preserving a graft-versus-malignancy effect.

Dean, Xiamen University Medical School, Xiamen, China

Dr. Zuguo is a Distinguished Professor of the Yangtze River Scholars of the Ministry of Education in 2002, winner of the 2003 National Outstanding Youth Fund, and chief scientist of the National Key Research and Development Program

He has long been engaged in the clinical and research work of ocular surface and corneal diseases. He has rich clinical experience and is a pioneer in the field of ocular surface diseases and dry eye in China. The main research areas are: dry eye, corneal neovascularization, corneal stem cells and tissue engineering, ophthalmic medical instruments and smart medical care.

Cheryl Rowe-Rendleman, PhD is a clinical research and development professional who, since 2005 has served as CEO of Omar Consulting Group, an ophthalmology consulting practice that specializes in creating business, regulatory, and clinical development know-how for people and companies with interests in eye diseases.

Mr. Hiller’s research experience originates from Vanderbilt University Medical Center where he transitioned from a Critical Care and Trauma Nurse to the coordination of research for the Department of Emergency Medicine. There he obtained experience in study initiation and management for pulmonary, pain management and Trauma studies. After two years of trial management, Mr. Hiller was recruited in 2003 by the Internal Review Board (IRB) at Vanderbilt as a medical protocol analyst and advanced through the ranks heading up the Radiation Safety Committee and acting as Team Leader for the Health Sciences 1 Committee. After 5 years in the Team Lead role, he moved into a project management position.

Partner, BakerHostetler, Atlanta, Georgia

Clayton Coley focuses on representing public and privately held companies in regulated industries, including financial services, healthcare and technology. He has extensive experience in a variety of transactions, including representation of strategic and financial buyers in merger and acquisition and venture capital transactions, and related aspects of federal and state securities laws, including SEC filings, and he advises investors and early-stage companies seeking financing through private equity transactions. Clayton also advises companies in venture capital, general corporate and operational matters, and on premerger notification filings with the Federal Trade Commission and the Department of Justice.

Partner, Kilpatrick Townsend, Atlanta, Georgia

Tina Williams McKeon is a registered patent attorney who focuses her practice on patent prosecution, post-grant proceedings, IP strategy and IP portfolio management for leading universities, research institutions, and corporations in the life sciences, pharmaceutical and biotechnology fields. Her biotechnology experience includes neuroscience, immunology, therapeutic antibodies, oncolytic virus therapy, stem cell technology and recombinant technologies in a variety of areas including food and food supplements. Dr. McKeon has worked extensively with medical technology and pharmaceuticals, including cardiac technology, imaging and diagnostics as well as small molecule pharmaceuticals and biologics.